• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Kids v Cancer

A PEDIATRIC CANCER THINK TANK

DONATE
  • GIVE KIDS A CHANCE act
  • RACE for Children Act
  • Creating Hope Act Pediatric Vouchers
  • CLIMB THE HILL
    • What is Climb the Hill Day?
    • Climb the Hill Youth Advocacy Day Sign Up
    • Video and photo gallery
    • (video) Climb the Hill Youth Advocacy Day — Why Do We Do It?
  • Compassionate Use Navigator
    • Information for Families
    • Information for Physicians
  • Who We Are
    • About Us
    • Mission and Impact
    • Contact
  • News & publications
    • Kids v Cancer in the News
    • Kids v Cancer Publications

Information for Physicians

PROJECT FACILITATE As of June 2019, the Food and Drug Administration Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals with submitting expanded access requests for investigational cancer therapies. FDA’s Project Facilitate creates a new call center which will be a single point of contact for physicians treating patients with cancer.
It includes:
• Providing contact information on where and how to submit a request to drug manufacturers; • Helping with filling out the required Form 3926; • Locating an IRB; • Inquiring with a company as to why an investigational drug is denied; • Collecting data on the numbers of granted and denied requests; • Collecting data on clinical outcomes of the use of investigational drugs.
PROJECT FACILITATE CONTACT INFORMATION • Healthcare providers may call Project Facilitate at (240) 402-0004 during regular business hours, 9 a.m. to 5 p.m. EST, M-F. Email: OncProjectFacilitate@fda.hhs.gov.

As a physician, you must have wished there would be more treatment options for patients who have not responded to available therapies. Thank you for your willingness to seek access to an investigational drug for your patient through compassionate use (expanded access). [What is it?]

Learn what we can do for you. Request our help

Application process overview

Identify the investigational drug and the company that makes it.
Apply to a drug manufacturer: Ask the company to provide the drug for your patient. Secure a Letter of Authorization from the company.
Apply to the U.S. Food and Drug Administration for authorization of a compassionate use request for your patient.
Apply for IRB approval.
Submit required safety reports.

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

Help us build a registry of requests – share your case

To develop effective compassionate use policies, it is necessary to understand the unmet need. Currently, only the number of requests that were granted by both the companies and FDA is known. FDA authorizes over 99% of requests it receives. There is no data on the numbers of applications submitted for pediatric patients, or applications that were denied by the manufacturers.

Let us know to which companies you have made compassionate use requests. Let us know the point of contact in the company that you used, whether the company responded and in how much time, and whether your request was ultimately granted.  And, please let us know how your patient did – was there any possible benefit from the drug?  Were there unexpected toxicities?

Please help us build a registry of compassionate use application outcomes by answering a few questions for our database, or email Elena Gerasimov, Program Director, at elena@kidsvcancer.org.

pen Print all application steps
as one document (PDF)


 

Apply to a Drug Manufacturer | Apply for FDA Authorization | Apply to IRB |
Safety Reports Requirements | Request Our Help

 

  • Compassionate Use Navigator
  • Request Our Help
  • Information for Families
    • Application Steps
  • Information for Physicians
    • Expanded Access Explained
    • Apply to a Drug Manufacturer
    • Apply for FDA Authorization
    • Apply to IRB
    • Safety Reports Requirements
    • Handout — All Application Steps
  • Forms and Templates
  • Reports, Legislation, Articles
  • Contribute to Our Outcomes Database
  • Compassionate Use News
link to Information for Families
Information for Families

 

Information for Physicians

  • Facebook
  • Twitter

DONATE SUBSCRIBE

Kids v Cancer · 3602 Newark Street NW · Washington D.C. 20016 · 646-361-3590 · contact

© 2023 Kids v Cancer · All Rights Reserved a 501(c)(3) nonprofit organization · EIN 27-1427784 · Privacy Policy · Terms of Use · Sitemap